Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Acticor Biotech SAS ALACT.PA
$6.08
-$0.02 (-0.33%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
75060500.00000000
-
week52high
11.00
-
week52low
5.10
-
Revenue
0
-
P/E TTM
-3
-
Beta
0.00000000
-
EPS
-1.24000000
-
Last Dividend
0.00000000
-
Next Earnings Date
23 мар 2023 г. в 19:00
Описание компании
Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was incorporated in 2013 and is headquartered in Paris, France.
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии